Apoptosis

Inavolisib View larger

Inavolisib

AT15375

CAS 2060571-02-8

More details

Molarity Calculation Cart®

HOW TO ORDER

$68.00

$68.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $30.60 Total: $3,060.00
150 $35.36 Total: $1,768.00
125 $41.48 Total: $1,037.00
110 $48.96 Total: $489.60
15 $57.80 Total: $289.00

Data sheet

Molecular FormulaC18H19F2N5O4
Molecular Weight407.37
CAS Numbers2060571-02-8
Storage Condition0C Short Term, -20C Long Term
SolubilityDMSO
Purity98% by HPLC
SMILES CodeC[C@H](Nc1ccc2-c3nc(cn3CCOc2c1)N1[C@@H](COC1=O)C(F)F)C(N)=O
ReferencesR Hong, Abstract PD4-14 GDC-0077 is a selective PI3Kalpha inhibitor that demonstrates robust efficacy in PIK3CA mutant breast cancer models as a single agent and in combination with standard of care therapies. 2017 San Antonio Breast Cancer Symposium.

More info

Inavolisib (GDC-0077) is an orally available and selective inhibitor of PI3K? (IC50=0.038 nM). Inavolisib is more selective for mutant versus wild-type PI3K?. Inavolisib exerts its activity by binding to the ATP binding site of PI3K, thereby inhibiting the phosphorylation of PIP2 to PIP3.